Apax Partners and Fremman Capital acquire co-controlling stakes in Palex Medical

Fremman Acquires Majority Stake in Palex from Ergon and Corpfin

October 20, 2021

Medical Devices

Fremman has acquired a majority stake in Palex, the leading distributor of high value-added MedTech equipment and solutions in Spain and Portugal, from Ergon Capital Partners and Corpfin Capital. Management, Ergon and Corpfin will remain minority shareholders as Fremman partners with the Palex team to pursue further consolidation and geographic expansion across Iberia and Europe.

Ergon Acquires Majority Stake in Palex from Corpfin and Knuth Family

December 23, 2019

Healthcare Services

Ergon Capital Partners has agreed to acquire a majority stake in Palex, the leading distributor of hospital equipment, technology and solutions in Spain and Portugal, from Corpfin Capital, the Knuth family and the management team. Corpfin will retain a minority stake alongside Ergon and Palex’s management as Ergon supports the company’s national and international growth plans.

Palex, backed by Ergon, acquires Comercial Rafer (Rafer)

February 3, 2021

Medical Devices

Palex, the Spain-and-Portugal MedTech distributor backed by Ergon, has acquired Comercial Rafer, S.L., a Zaragoza-based distributor of reagents and laboratory instruments focused on IVD and histocompatibility. The add-on expands Palex's IVD and laboratory diagnostics offering and brings Rafer's ~40 employees, nationwide salesforce and technical service into the Palex platform.

Abenex Continuation Fund Acquires Majority Stake in Europa Group; Europa Acquires APM International

April 29, 2024

Healthcare Services

Abenex closed an oversubscribed continuation fund (~€300m) to acquire a majority stake in Europa Group from its Abenex V portfolio, making Abenex the group's majority shareholder while founders remain significant owners and management continues. As part of its buy-and-build strategy supported by the recapitalization, Europa Group also acquired APM International (a France-based healthcare press agency) to strengthen its medical information and publishing capabilities.

Funds Advised by Permira Acquire Neuraxpharm from Funds Advised by Apax Partners

September 22, 2020

Pharmaceuticals

Funds advised by Permira have agreed to acquire the controlling stake in Neuraxpharm, a leading European specialty pharmaceuticals company focused on central nervous system (CNS) disorders, from funds advised by Apax Partners. Financial terms were not disclosed; Neuraxpharm had annual revenues in excess of €460 million and around 850 employees under Apax's ownership.

EQT Private Equity and Goldman Sachs Asset Management Acquire Parexel from Pamplona Capital Management

July 2, 2021

Healthcare Services

EQT Private Equity (EQT IX) and Goldman Sachs Asset Management's Private Equity business have agreed to acquire Parexel from Pamplona Capital Management for an enterprise value of USD 8.5 billion. Parexel, a global clinical research organization co-headquartered in Durham, North Carolina and Newton, Massachusetts, employs more than 17,000 people and provides outsourced clinical development, regulatory, market access and consulting services to the pharma and biotech industry.